Search

Cookies

We use cookies to improve your experience. By continuing, you accept our use of cookies.

Business

Indian Markets Surge: Sensex Up 639 Points, Nifty Hits 24,093 Amid Global Optimism

· · 3 min read

Indian benchmark indices Sensex and Nifty climbed over 0.8% on Monday, April 27, 2026, driven by short covering, value buying, and improved global sentiment. Sun Pharma and Reliance Industries led the gains, pushing the Sensex up 639 points and Nifty to 24,093.

Indian equity markets witnessed a robust rally on Monday, April 27, 2026, with key benchmark indices closing significantly higher. The Sensex surged by 639.42 points, or 0.83%, to settle at 77,303.63, while the Nifty 50 advanced by 194.75 points, or 0.81%, reaching 24,092.70. This positive momentum was largely attributed to a combination of renewed global optimism and strategic corporate developments.

Global Cues and Domestic Drivers Fuel Rally

Investor sentiment received a significant boost from improving global cues, particularly reports suggesting a potential de-escalation in tensions between the US and Iran concerning the Strait of Hormuz. This development eased fears of supply disruptions and bolstered global risk appetite, providing a stable environment for domestic markets to flourish.

According to Vinod Nair, Head of Research at Geojit Investments, the prospect of resumed US-Iran talks, coupled with stronger-than-expected Q4 FY26 earnings, significantly improved investor confidence. Hariprasad K, SEBI-registered Research Analyst and Founder at Livelong Wealth, also highlighted the de-escalation reports as a key catalyst, supporting market stabilization and growth.

Aakash Shah, Research Analyst at Choice Equity Broking, noted that the session's strength stemmed from substantial short covering and value buying following a recent market correction. This indicated that investors were selectively accumulating quality stocks at lower valuations. Broader markets also participated in the upward movement, reflecting a widespread improvement in sentiment across sectors like Banking, FMCG, capital goods, consumer discretionary, and manufacturing.

Sun Pharma and Reliance Industries Lead Gains

Several heavyweights contributed significantly to the indices' climb:

  • Sun Pharmaceuticals Industries Ltd: The pharmaceutical major was a top Sensex gainer, soaring 6.98% to Rs 1,732.95. This surge followed the announcement of its acquisition of Organon & Co for approximately $3.99 billion in total equity value, with an enterprise valuation of about $11.75 billion.
  • Reliance Industries Ltd (RIL): RIL shares gained 3.19% to Rs 1,370. Despite reporting muted Q4 results, investor confidence in Reliance Jio Platform Ltd and an upgrade from 'Accumulate' to 'Buy' by Elara Securities drove its performance. Elara Securities cited an 8% correction in the stock over the past six months as a factor, anticipating stronger Gross Refining Margins (GRMs) post-normalization of Hormuz traffic.

Other notable contributors included HDFC Bank Ltd and several IT companies, which attracted investor interest due to valuation comfort and long-term accumulation strategies, despite reporting subdued results.

Market Outlook and Concerns

While the market showed strong recovery, some concerns persist. Inflation risks remain a key consideration for investors. Market participants are expected to closely monitor the upcoming US Federal Reserve's policy announcement, particularly regarding its medium-term interest rate trajectory, which could influence future market movements.

Related